B Bellei, E Migliano, M Picardo - Experimental Dermatology, 2022 - Wiley Online Library
Stem cell‐mediated therapies in combination with biomaterial and growth factor‐based approaches in regenerative medicine are rapidly evolving with increasing application …
Inflammatory response in COVID-19 contributes greatly to disease severity. Mesenchymal Stem Cells (MSCs) have the potential to alleviate inflammation and reduce mortality and …
COVID-19 emerged in December 2019 in Wuhan, China, spread worldwide rapidly, and caused millions of deaths in a short time. Many preclinical and clinical studies were …
PC Lee, CZ Li, CT Lu, MH Zhao, SM Lai… - International Journal …, 2023 - Taylor & Francis
Purpose Larger nanoparticles of bioactive compounds deposit high concentrations in follicular ducts after skin penetration. In this study, we investigated the effects of microcurrent …
AM Kirkham, M Monaghan, AJM Bailey, R Shorr… - Cytotherapy, 2022 - Elsevier
Background Mesenchymal stem/stromal cells (MSCs) and their secreted products are a promising therapy for COVID-19 given their immunomodulatory and tissue repair …
Background/Aim: Box A is a highly conserved DNA-binding domain of high-mobility group box 1 (HMGB1) and has been shown to reverse senescence and aging features in many cell …
Abstract The mesenchymal Stem Cells (MSCs) is one of the leading contender in therapeutic management of cytokine storm implicated in the COVID-19 and other …
Since the first appearance of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS- CoV-2) in December 2019, the disease has displayed a remarkable interindividual …
Background and objective Ulcerative colitis (UC) causes ulcers in the colon and rectum, leading to abdominal pain, diarrhea, and rectal bleeding, and if left untreated, can lead to …